METHODS AND APPARATUS FOR ANALYZING AND LOCALLY TREATING A BODY LUMEN

• US 20100069760A1
• Filed: 09/17/2009
• Published: 03/18/2010
• Est. Priority Date: 09/17/2008
• Status: Abandoned Application

• Current Assignee: CorNova, Inc.
• Original Assignee: CorNova, Inc.
• Inventors: Tang, Jing
• Application Number:
  US12/561,756
• Publication Number:
  US 20100069760A1
• Time in Patent Office: Days
• US Class Current: 600/478
• CPC Class Codes: A61B 5/0066 Optical coherence imaging
• CPC Class Codes: A61B 5/0071 by measuring fluorescence emission
• CPC Class Codes: A61B 5/0075 by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy A61B5/0071 takes precedence
• CPC Class Codes: A61B 5/0084 for introduction into the body, e.g. by catheters A61B5/1459 takes precedence
• CPC Class Codes: A61B 5/0086 using infrared radiation
• CPC Class Codes: A61B 5/02007 Evaluating blood vessel condition, e.g. elasticity, compliance

Abstract

A method and apparatus for analyzing and treating internal lumens is provided. The apparatus includes a catheterized device integrating an optical probe and local treatment delivery system. The probe component includes fiber optic lines that can be used in conjunction with visible and/or near infrared spectroscopy to analyze various characteristics of tissues, including chemical, blood, and oxygen content, in order to locate those tissues associated with diseased lumens, to determine the best location for applying treatment, and to monitor treatment and its effects. Physically integrated with the probe component is a treatment component for delivering localized treatments including stem cells, antibiotics, gene therapy, neoplasty, and sclerosant drugs, etc. A control system coordinates operation of the catheter, including performing chemometric analysis with the use of model data, and for providing control and visual feedback to an operator.

Claims

1. An apparatus for probing and treating internal body organs comprising:

a catheter having a fiber probe arrangement and one or more treatment lumens;

a needle-tip inserter integrated with said fiber probe arrangement and said one or more treatment lumens;

a spectrometer connected to said fiber probe arrangement;

an analysis and treatment control system connected to said catheter and spectrometer, said analysis and control system programmed to characterize and locate damaged tissue within a wall of a body lumen and to treat said damaged tissue with said needle-tip inserter and said one or more treatment lumens.

2. The apparatus of claim 1, wherein said needle tip inserter comprises the probe ends of one or more fibers of said fiber probe arrangement and a fluid dispersal port for said one or more treatment lumens.

3. The apparatus of claim 1, wherein said needle tip inserter is at least partially retractable within said catheter so as to ease the advancement of said catheter in said internal body organs while permitting optical analysis.

4. The apparatus of claim 1, wherein the analysis and treatment control system is programmed to analyze spectroscopic data, the analysis of the spectroscopic data including distinguishing the types and conditions of tissue within and surrounding the wall of the body lumen.

5. The apparatus of claim 4, wherein distinguishing the types and conditions of tissue within and surrounding the wall of a body lumen includes characterizing and locating tissues associated with at least one of stenosis or thrombosis.

6. The apparatus of claim 5, wherein characterizing and locating the tissues associated with stenosis or thrombosis includes detecting levels of at least one of collagen content, lipid content, inflammation, fibrosis, calcification, oxygen content, and the relative positioning of pathophysiologic conditions within the plaque.

7. The apparatus of claim 1, wherein said analysis and control system is configured to perform spectroscopic scans across wavelengths in the range of approximately 300 to 2500 nanometers.

8. The apparatus of claim 1, wherein the analysis and control system is configured to estimate relative distances between the distal end of said fiber probe arrangement and tissue analyzed by said spectrometry comparing spectroscopic absorbance peaks associated with collection fibers of said fiber probe arrangement having terminating ends separated from each other at a predetermined distance.

9. The catheter of claim 1 further comprising an angle control wire for adjusting the angle of the distal end of said catheter.

10. A method for treating a body lumen, said method comprising:

inserting into a patient'"'"'s lumen a catheter integrated with a fiber optic analysis probe, an integrated inserter for perforating targeted tissue, and a treatment delivery conduit;

characterizing and locating the tissue of the lumen to be treated with radiation delivered and collected through said fiber optic analysis probe;

positioning said inserter to perforate targeted tissue and deliver treatment with information obtained through said fiber optic analysis probe; and

injecting a therapeutic agent through said treatment delivery conduit.

11. The method of claim 10, wherein the body lumen to be treated is associated with at least one of stenosis or thrombosis.

12. The method of claim 10, wherein characterizing and locating tissue of the lumen to be treated comprises:

obtaining spectroscopic data from radiation delivered to and collected from said tissue to be treated via said fiber optic analysis probe; and

comparing said spectroscopic data with previously stored data characteristic of a lumen in order to identify the type of tissue being analyzed and to locate the position of said tissue being analyzed relative to said catheter.

13. The method of claim 12, wherein obtaining spectroscopic data comprises at least one of the methods including diffuse-reflectance spectroscopy, fluorescence spectroscopy, Raman spectroscopy, scattering spectroscopy, optical coherence reflectometery, and optical coherence tomography.

14. The method of claim 10, wherein at least one of gases, fluids, and compounds are analyzed, said at least one of gases, fluids, and compounds are selected from the group including collagen, calcium, oxygen, hemoglobin, and myoglobin.

15. The method of claim 10, wherein characterizing the tissue to be treated involves chemometric analysis selected from the group of techniques consisting of Principle Component Analysis (PCA) with Mahalanobis Distance, PCA with K-nearest neighbor, PCA with Euclidean Distance, Partial Least Squares Discrimination Analysis, augmented Residuals, bootstrap error-adjusted single-sample technique, and Soft Independent Modeling of Class Analogy.

16. The method of claim 10, wherein the spectroscopic data is obtained from radiation spanning wavelengths between approximately 750 to 2500 nanometers.

17. The method of claim 16, wherein radiation is delivered to tissue or blood at a wavelength of about 380 nanometers and scanned to detect fluorescence at about 320 nanometers in order to identify the presence of collagen.

18. The method of claim 10, wherein, during positioning of said catheter for delivery of treatment, said integrated inserter for perforating targeted tissue remains at least partially retracted in said catheter prior to perforation into tissue targeted for treatment.

19. The method of claim 10, wherein, prior to and during extension of said inserter, a wall of the lumen before which said inserter is positioned is concurrently analyzed and monitored to prevent complete perforation of said inserter through the entire wall of said lumen.

20. The method of claim 10, wherein the release of agents is monitored with said fiber optic probe and controlled using feedback from said monitoring.